Drugs / Caltrate Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04276636 | Oct 2020 → Mar 2021 | Crohn disease, vitamin D deficiency | Second Affiliated Hospital of Wenzhou Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Caltrate Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04276636 ↗ |
| Route | Oral | “given orally with Caltrate Pill 0.6 g / d” NCT04276636 ↗ |